The Hemato-oncology Division, opened in 1997, is a multidisciplinary team of health care professionals, dedicated to two main objectives in the field of hematological malignancies:
The development of innovative clinical research protocols: the division combines innovative research discoveries with the best clinical treatments to improve outcomes for patients.
HAEMATONCOLOGIC MALIGNANCES
Hematologic malignancies, also called blood cancers, are cancers that affect cells of the bone marrow, the lymphatic and the immune system. Blood cancer originates from the proliferation and the survival of the two major blood cell lineages: myeloid and lymphoid cell lines.
The IEO International Office is fully dedicated to providing a tailored welcome and a comfortable hospital stay, by meeting all individual needs.
IEO Second Opinion is a service for who would like to confirm the diagnosis and treatments recommended by other physicians.
An assistant from the IEO International Office will be glad to give you all information needed and personally assist you.